Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions

American Journal of Roentgenology

Volumn 192, Issue 2, 2009, Pages

  Smith, Ethan A ^a   Carlos, Ruth C ^a   Junck, Larry R ^a   Tsien, Christina I ^a   Elias, Augusto ^a   Sundgren, Pia C ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Brain neoplasms; MR spectroscopy; Postradiation changes; Postradiation necrosis; Recurrent glioma

Indexed keywords

CHOLINE; CREATINE; GADOLINIUM PENTETATE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASTROCYTOMA; BRAIN LEVEL; CHILD; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; EPENDYMOMA; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MALE; MEDULLOBLASTOMA; METABOLITE; NEUROECTODERM TUMOR; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGODENDROGLIOMA; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RADIATION INJURY; RANK SUM TEST; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHOLINE; CONTRAST MEDIA; CREATINE; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; GADOLINIUM; HUMANS; LOGISTIC MODELS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 59349093308     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.3934     Document Type: Article

References (25)

1. Valk PE, Dillon WP. Radiation injury of the brain. AJNR 1991; 12:45-62
2. Bonavita S, Di Salle F, Tedeschi G. Proton MR spectroscopy in neurologic disorders. Eur Radiol 1999; 30:125-131
3. Marks JE, Baglan RJ, Prassad SC, Blank WF. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 1981; 7:243-252
4. Kumar AJ, Leeds NE, Fuller GN, et al. Malignant gliomas: MRI spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. Radiology 2000; 217:377-384
5. Rock JP, Hearschen D, Scarpace L, et al. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis. Neurosurgery 2002; 51:912-920
6. Croteau D, Scarpace L, Hearschen D, et al. Correlation between MR spectroscopy imaging and imaging-guided biopsies: semiquantitative and qualitative histopathologic analyses of patients with untreated gliomas. Neurosurgery 2001; 49:823-829
7. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR 2001; 22:604-612
8. Fulham MJ, Bizzi A, Dieta MJ, et al. Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance. Radiology 1992; 185:675-686
9. Weybright P, Sundgren PC, Maly P, et al. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR 2005; 185:1471-1476
10. Weybright P, Maly P, Gomez-Hassan D, Blaesing C, Sundgren PC. MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in the posterior fossa after tumor treatment. Neuroradiology 2004; 46:541-549
11. Taylor JS, Langston JW, Reddick WE, et al. Clinical value of proton MR spectroscopy for differentiating recurrent or residual brain tumor from delayed cerebral necrosis. Int J Radiat Oncol Biol Phys 1996; 36:1251-1261
12. Zeng QS, Li CF, Zhang K, Liu H, Kang XS, Zhen JH. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 2007; 84:63-69
13. Joseph PM, Shetty A. A comparison of selective saturation and selective echo chemical shift imaging techniques. Magn Reson Imaging 1988; 6:421-430
14. Petrou M, Sundgren PC, Pang Y, Foerster B, Rohrer S, Chenevert TL. Manually adjusted versus vendor-preset definition of metabolite boundaries impact on proton metabolite ratios. Acad Radiol 2007; 14:340-343
15. McKinney PA. Brain tumours: incidence, survival, and aetiology. J Neurol Neurosurg Psychiatry 2004; 75[suppl 2]:ii12-ii17
16. DeAngelis LM. Brain tumors. N Engl J Med 2001; 344:114-123
17. Herfarth KK, Gutwein S, Debus J. Postoperative radiation therapy of astrocytomas. Semin Surg Oncol 2001; 20:13-23
18. Lin A, Bluml S, Mamelak AM. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neurooncol 1999; 45:69-81
19. Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users' guides to medical literature XXV: evidence-based medicine - principles for applying the users' guides to patient care. JAMA 2000; 284:1290-1296
20. Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji SK. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? AJNR 2007; 28:328-334
21. 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiation therapy. J Nucl Med 2008; 49:694-699
22. Sugahara T, Korogi Y, Tomiguchi S, et al. Post-therapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MRI for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR 2000; 21:901-909
23. Jain R, Scarpace L, Ellika S, et al. First-pass perfusion CT: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis. Neurosurgery 2007; 61:778-786
24. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity and predictive values of perfusion MRI and proton MR spectroscopic imaging compared with conventional MRI. AJNR 2003; 24:1989-1998
25. Al-Okaili RN, Kreja J, Woo JH, et al. Intraaxial brain masses: MRI-based diagnostic strategy - initial experience. Radiology 2007; 243:539-550